Showing results 7 to 9 of 9
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity Journal:Annals of Hematology | 2017 | ||
Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients Journal:Journal of Clinical Pathology | 2006 | ||
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults Journal:Blood Cancer Journal | 2020 |